| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Gastrointestinal Research Laboratory, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029 [S. O., S. H. I.], and CIBA-Corning Diagnostics, East Walpole, Massachusetts 02032 [P. J. M.]
The sialosyl-Tn (STn) antigen is a mucin-associated carbohydrate antigen expressed by a variety of adenocarcinomas. In the colon, expression of this antigen has been associated with a poor prognosis, independent of tumor stage or histology. The present study was performed to determine whether this adverse clinical outcome might he due to an interaction between STn-positive mucin and natural killer (NK) cell cytotoxicity. Ovine submaxillary mucin (OSM), a mucin highly rich in STn antigen, partially inhibited NK cell cytotoxicity against K562 target cells, but only at high concentrations. Low concentrations of OSM were not inhibitory but became markedly inhibitory in the presence of ammonium ions. Two other STn-positive submaxillary mucins also markedly inhibited NK cytotoxicity when combined with ammonium ions. Removal of sialic acid from OSM reversed the OSM/ammonium-mediated inhibition of NK cell activity. Unlike the submaxillary mucins, two mucins derived from human breast and lung cancer cells which lack the STn antigen, did not inhibit NK cell activity in this system. Likewise, four other non-mucin glycoproteins which lack STn expression did not inhibit NK cells despite having levels of sialic acid that were, in some cases, comparable to submaxillary mucin. These results indicate that mucins bearing the cancer-associated STn antigen can effectively inhibit NK cell cytotoxicity in the presence of ammonium ions. While this NK cell inhibition is likely to be caused by ammonium, mucin markedly enhances this effect, thereby implicating a novel immunomodulatory property of mucin.
1 Supported by Public Health Service Grant CA52491, and awards from the Aaron Diamond Foundation and The Chemotherapy Foundation.
2 Recipient of an Irma T. Hirschl Career Scientist Award. To whom requests for reprints should be addressed, at Division of Gastroenterology, Box 1069, Mount Sinai Hospital, 1 Gustave L. Levy Place, New York, NY 10029.
Received 3/11/92. Accepted 6/18/92.
This article has been cited by other articles:
|
|
 |
|
  T. Ju, G. S. Lanneau, T. Gautam, Y. Wang, B. Xia, S. R. Stowell, M. T. Willard, W. Wang, J. Y. Xia, R. E. Zuna, et al. Human Tumor Antigens Tn and Sialyl Tn Arise from Mutations in Cosmc Cancer Res., March 15, 2008; 68(6): 1636 - 1646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Gilewski, G. Ragupathi, M. Dickler, S. Powell, S. Bhuta, K. Panageas, R. R. Koganty, J. Chin-Eng, C. Hudis, L. Norton, et al. Immunization of High-Risk Breast Cancer Patients with Clustered sTn-KLH Conjugate plus the Immunologic Adjuvant QS-21 Clin. Cancer Res., May 15, 2007; 13(10): 2977 - 2985. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Julien, E. Adriaenssens, K. Ottenberg, A. Furlan, G. Courtand, A.-S. Vercoutter-Edouart, F.-G. Hanisch, P. Delannoy, and X. Le Bourhis ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity Glycobiology, January 1, 2006; 16(1): 54 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. T. Marcos, S. Pinho, C. Grandela, A. Cruz, B. Samyn-Petit, A. Harduin-Lepers, R. Almeida, F. Silva, V. Morais, J. Costa, et al. Role of the Human ST6GalNAc-I and ST6GalNAc-II in the Synthesis of the Cancer-Associated Sialyl-Tn Antigen Cancer Res., October 1, 2004; 64(19): 7050 - 7057. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Hamada, S Matsukita, M Goto, S Kitajima, S K Batra, T Irimura, K Sueyoshi, K Sugihara, and S Yonezawa Mucin expression in pleomorphic adenoma of salivary gland: a potential role for MUC1 as a marker to predict recurrence J. Clin. Pathol., August 1, 2004; 57(8): 813 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Wang, M. Goto, Y. S. Kim, M. Higashi, K. Imai, E. Sato, and S. Yonezawa Altered GalNAc-{alpha}-2,6-sialylation Compartments for Mucin-associated Sialyl-Tn Antigen in Colorectal Adenoma and Adenocarcinoma J. Histochem. Cytochem., December 1, 2001; 49(12): 1581 - 1592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Singh, B.J. Campbell, L.-G. Yu, D.G. Fernig, J.D. Milton, R.A. Goodlad, A.J. FitzGerald, and J.M. Rhodes Cell surface-expressed Thomsen-Friedenreich antigen in colon cancer is predominantly carried on high molecular weight splice variants of CD44 Glycobiology, July 1, 2001; 11(7): 587 - 592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kawamoto, J. Shoda, T. Irimura, N. Miyahara, M. Furukawa, T. Ueda, T. Asano, M. Kano, N. Koike, K. Fukao, et al. Expression of MUC1 Mucins in the Subserosal Layer Correlates with Postsurgical Prognosis of Pathological Tumor Stage 2 Carcinoma of the Gallbladder Clin. Cancer Res., May 1, 2001; 7(5): 1333 - 1342. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. J. Kim, L. Borsig, N. M. Varki, and A. Varki P-selectin deficiency attenuates tumor growth and metastasis PNAS, August 4, 1998; 95(16): 9325 - 9330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-J. Yu, J.-Y. Shew, C.-T. Shun, H.-T. Lin, S.-H. Kuo, K.-T. Luh, and P.-C. Yang Quantitative Analysis of mRNA Encoding MUC1, MUC2, and MUC5AC Genes: A Correlation between Specific Mucin Gene Expression and Sialomucin Expression in Non-Small Cell Lung Cancer Am. J. Respir. Cell Mol. Biol., May 1, 1998; 18(5): 643 - 652. [Abstract] [Full Text]
|
|
|
|
 |
|
 Corrigenda for vol. 155, p. 1419 Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 677 - 678. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |
